These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25985579)
21. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution. Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316 [TBL] [Abstract][Full Text] [Related]
22. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes. Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947 [TBL] [Abstract][Full Text] [Related]
23. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform. Kaji H; Kume T Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137 [TBL] [Abstract][Full Text] [Related]
24. Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9. Kishi N; Takasuka A; Kokawa Y; Isobe T; Taguchi M; Shigeyama M; Murata M; Suno M; Hanioka N Xenobiotica; 2016; 46(4):289-95. PubMed ID: 26247833 [TBL] [Abstract][Full Text] [Related]
25. Hepatic and intestinal glucuronidation of mono(2-ethylhexyl) phthalate, an active metabolite of di(2-ethylhexyl) phthalate, in humans, dogs, rats, and mice: an in vitro analysis using microsomal fractions. Hanioka N; Isobe T; Kinashi Y; Tanaka-Kagawa T; Jinno H Arch Toxicol; 2016 Jul; 90(7):1651-7. PubMed ID: 26514348 [TBL] [Abstract][Full Text] [Related]
26. Identification of the human liver UDP-glucuronosyltransferase involved in the metabolism of p-ethoxyphenylurea (dulcin). Uesawa Y; Staines AG; Lockley D; Mohri K; Burchell B Arch Toxicol; 2007 Mar; 81(3):163-8. PubMed ID: 16897040 [TBL] [Abstract][Full Text] [Related]
27. Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver. Mano Y; Usui T; Kamimura H Eur J Clin Pharmacol; 2007 Mar; 63(3):289-96. PubMed ID: 17245571 [TBL] [Abstract][Full Text] [Related]
28. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms. Uchihashi S; Fukumoto H; Onoda M; Hayakawa H; Ikushiro S; Sakaki T Drug Metab Dispos; 2011 May; 39(5):803-13. PubMed ID: 21346002 [TBL] [Abstract][Full Text] [Related]
29. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases. Ruan JQ; Yan R Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472 [TBL] [Abstract][Full Text] [Related]
30. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences. Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899 [TBL] [Abstract][Full Text] [Related]
31. Cis-resveratrol glucuronidation kinetics in human and recombinant UGT1A sources. Iwuchukwu OF; Nagar S Xenobiotica; 2010 Feb; 40(2):102-8. PubMed ID: 20017604 [TBL] [Abstract][Full Text] [Related]
32. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes. Mano Y; Usui T; Kamimura H Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043 [TBL] [Abstract][Full Text] [Related]
33. New Insights into SN-38 Glucuronidation: Evidence for the Important Role of UDP Glucuronosyltransferase 1A9. Xiao L; Zhu L; Li W; Li C; Cao Y; Ge G; Sun X Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):424-428. PubMed ID: 29076612 [TBL] [Abstract][Full Text] [Related]
34. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol. Chen M; LeDuc B; Kerr S; Howe D; Williams DA Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037 [TBL] [Abstract][Full Text] [Related]
35. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin. Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019 [TBL] [Abstract][Full Text] [Related]
36. In Vitro Evaluation of the Effect of 7-Methyl Substitution on Glucuronidation of Daphnetin: Metabolic Stability, Isoform Selectivity, and Bioactivity Analysis. Liang SC; Ge GB; Xia YL; Zhang JW; Qi XY; Tu CX; Yang L J Pharm Sci; 2015 Oct; 104(10):3557-64. PubMed ID: 26104686 [TBL] [Abstract][Full Text] [Related]
37. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases. Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802 [TBL] [Abstract][Full Text] [Related]
38. Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs. Knights KM; Winner LK; Elliot DJ; Bowalgaha K; Miners JO Br J Clin Pharmacol; 2009 Sep; 68(3):402-12. PubMed ID: 19740398 [TBL] [Abstract][Full Text] [Related]
39. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction. Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253 [TBL] [Abstract][Full Text] [Related]
40. Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9). Takahashi H; Maruo Y; Mori A; Iwai M; Sato H; Takeuchi Y Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):131-6. PubMed ID: 18816295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]